Randomized, open-label, parallel-group, multicenter study of the efficacy and tolerability of IV gatifloxacin with the option for oral stepdown gatifloxacin versus IV ceftriaxone (with or without erythromycin or clarithromycin) with the option for oral stepdown clarithromycin for treatment of patients with mild to moderate community-acquired pneumonia requiring hospitalization

João Carlos Corrêa; Roberto Badaró; Chaiwat Bumroongkit; Jorge Raúl Mera; Alberto Lorenzo Dolmann; Luis Guillermo Juárez Martínez; Lusane Romero Mayrinck; Ricardo Tamez; Joanna Y Yang

doi:10.1016/s0149-2918(03)80132-7

Randomized, open-label, parallel-group, multicenter study of the efficacy and tolerability of IV gatifloxacin with the option for oral stepdown gatifloxacin versus IV ceftriaxone (with or without erythromycin or clarithromycin) with the option for oral stepdown clarithromycin for treatment of patients with mild to moderate community-acquired pneumonia requiring hospitalization

Clinical Therapeutics ◽

10.1016/s0149-2918(03)80132-7 ◽

2003 ◽

Vol 25 (5) ◽

pp. 1453-1468 ◽

Cited By ~ 13

Author(s):

João Carlos Corrêa ◽

Roberto Badaró ◽

Chaiwat Bumroongkit ◽

Jorge Raúl Mera ◽

Alberto Lorenzo Dolmann ◽

...

Keyword(s):

Multicenter Study ◽

Community Acquired Pneumonia ◽

Open Label ◽

Parallel Group

Download Full-text

A Randomized, Parallel-Group, Open-Label, Multicenter Study to Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing with a New Lower-Concentration (0.025%) Clobetasol Propionate Cream

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.2.supp.84 ◽

2018 ◽

Vol 2 ◽

pp. S83

Author(s):

Zoe D Draelos ◽

Joseph F Fowler ◽

Raymond Cornelison

Keyword(s):

Multicenter Study ◽

Drug Absorption ◽

Clobetasol Propionate ◽

Adrenal Suppression ◽

Open Label ◽

Multiple Dosing ◽

Parallel Group ◽

Systemic Drug

Download Full-text

Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: A randomized, open-label, multicenter study of clinical efficacy and tolerability

Clinical Therapeutics ◽

10.1016/s0149-2918(02)80088-1 ◽

2002 ◽

Vol 24 (11) ◽

pp. 1915-1936 ◽

Cited By ~ 49

Author(s):

Hartmut Lode ◽

Thomas M File ◽

Lionel Mandell ◽

Peter Ball ◽

Rienk Pypstra ◽

...

Keyword(s):

Clinical Efficacy ◽

Multicenter Study ◽

Sequential Therapy ◽

Community Acquired Pneumonia ◽

Open Label

Download Full-text

The EXERRT trial: “EXErcise to Regadenoson in Recovery Trial”: A phase 3b, open-label, parallel group, randomized, multicenter study to assess regadenoson administration following an inadequate exercise stress test as compared to regadenoson without exercise for myocardial perfusion imaging using a SPECT protocol

Journal of Nuclear Cardiology ◽

10.1007/s12350-017-0813-3 ◽

2017 ◽

Vol 24 (3) ◽

pp. 788-802 ◽

Cited By ~ 11

Author(s):

Gregory S. Thomas ◽

S. James Cullom ◽

Therese M. Kitt ◽

Kathleen M. Feaheny ◽

Karthikeyan Ananthasubramaniam ◽

...

Keyword(s):

Myocardial Perfusion Imaging ◽

Myocardial Perfusion ◽

Multicenter Study ◽

Perfusion Imaging ◽

Stress Test ◽

Exercise Stress Test ◽

Exercise Stress ◽

Open Label ◽

Parallel Group

Download Full-text

Comprehensive Evaluation of Combination Therapy with Basal Insulin and Either Lixisenatide or Vildagliptin in Japanese Patients with Type 2 Diabetes: A Randomized, Open-Label, Parallel-Group, Multicenter Study

Diabetes Therapy ◽

10.1007/s13300-018-0505-2 ◽

2018 ◽

Vol 9 (5) ◽

pp. 2067-2079 ◽

Cited By ~ 1

Author(s):

Natsu Otowa-Suematsu ◽

Kazuhiko Sakaguchi ◽

Tomoaki Nakamura ◽

Kenta Hara ◽

Minoru Kishi ◽

...

Keyword(s):

Type 2 Diabetes ◽

Combination Therapy ◽

Multicenter Study ◽

Basal Insulin ◽

Comprehensive Evaluation ◽

Japanese Patients ◽

Open Label ◽

Parallel Group

Download Full-text

Tolerability of a Salmeterol Xinafoate/Fluticasone Propionate Hydrofluoroalkane Metered-Dose Inhaler in Adolescent and Adult Patients with Persistent Asthma: A 52-Week, Open-Label, Stratified, Parallel-Group, Multicenter Study

Clinical Therapeutics ◽

10.1016/j.clinthera.2007.07.021 ◽

2007 ◽

Vol 29 (7) ◽

pp. 1390-1402 ◽

Cited By ~ 6

Author(s):

Robert L. Cowie ◽

Louis-Philippe Boulet ◽

Paul K. Keith ◽

Catherine A. Scott-Wilson ◽

Karen W. House ◽

...

Keyword(s):

Fluticasone Propionate ◽

Multicenter Study ◽

Persistent Asthma ◽

Adult Patients ◽

Dose Inhaler ◽

Metered Dose Inhaler ◽

Open Label ◽

Salmeterol Xinafoate ◽

Parallel Group ◽

Metered Dose

Download Full-text

Oral gatifloxacin in outpatient community-acquired pneumonia: results from TeqCES, a community-based, open-label, multicenter study

Diagnostic Microbiology and Infectious Disease ◽

10.1016/s0732-8893(02)00447-9 ◽

2002 ◽

Vol 44 (1) ◽

pp. 85-91 ◽

Cited By ~ 16

Author(s):

Mark Gotfried ◽

Thomas C. Quinn ◽

Samantha Gothelf ◽

Matthew A. Wikler ◽

C.Douglas Webb ◽

...

Keyword(s):

Multicenter Study ◽

Community Acquired Pneumonia ◽

Open Label ◽

Community Based

Download Full-text

Comparison of latanoprost with fixed-combination dorzolamide and timolol in adult patients with elevated intraocular pressure: An eight-week, randomized, open-label, parallel-group, multicenter study in Latin America

Clinical Therapeutics ◽

10.1016/s0149-2918(04)90075-6 ◽

2004 ◽

Vol 26 (5) ◽

pp. 755-768 ◽

Cited By ~ 31

Author(s):

Remo Sussana ◽

Wang-Pui Sheu ◽

Latin American Glaucoma Society

Keyword(s):

Latin America ◽

Intraocular Pressure ◽

Multicenter Study ◽

Fixed Combination ◽

Adult Patients ◽

Open Label ◽

Parallel Group ◽

Elevated Intraocular Pressure

Download Full-text

Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study

Advances in Therapy ◽

10.1007/s12325-018-0855-1 ◽

2018 ◽

Vol 36 (2) ◽

pp. 462-477 ◽

Cited By ~ 4

Author(s):

Nassim Kamar ◽

Elisabeth Cassuto ◽

Giovanni Piotti ◽

Mirco Govoni ◽

Giorgia Ciurlia ◽

...

Keyword(s):

Kidney Transplant ◽

Multicenter Study ◽

De Novo ◽

Prolonged Release ◽

Transplant Recipients ◽

Kidney Transplant Recipients ◽

Open Label ◽

Once Daily ◽

Parallel Group

Download Full-text

Rosuvastatin versus atorvastatin in achieving lipid goals in patients at high risk for cardiovascular disease in clinical practice: A randomized, open-label, parallel-group, multicenter study (DISCOVERY Alpha study)

Current Therapeutic Research ◽

10.1016/j.curtheres.2006.02.005 ◽

2006 ◽

Vol 67 (1) ◽

pp. 21-43 ◽

Cited By ~ 12

Author(s):

Azan S. Binbrek ◽

Avishay Elis ◽

Muayed Al-Zaibag ◽

Jaan Eha ◽

Irena Keber ◽

...

Keyword(s):

Cardiovascular Disease ◽

Clinical Practice ◽

High Risk ◽

Multicenter Study ◽

Open Label ◽

Parallel Group

Download Full-text

Efficacy and safety of telithromycin 800 mg once daily for 7 days in community-acquired pneumonia: an open-label, multicenter study

BMC Infectious Diseases ◽

10.1186/1471-2334-5-43 ◽

2005 ◽

Vol 5 (1) ◽

Cited By ~ 13

Author(s):

Charles M Fogarty ◽

Tushar C Patel ◽

Lala M Dunbar ◽

Bruno P Leroy

Keyword(s):

Multicenter Study ◽

Community Acquired Pneumonia ◽

Efficacy And Safety ◽

Open Label ◽

Once Daily

Download Full-text